Key result
Drug-induced long QT syndrome warrants prompt identification, risk factor modification, and offending medication withdrawal.
Why the study?
Drug-induced long QT interval syndrome is a rare but potentially fatal complication requiring comprehensive understanding of its prevention, diagnosis, and treatment.
Drug-induced long QT syndrome is a potentially fatal complication of both cardiac and non-cardiac medications that requires careful risk assessment, monitoring, and prompt management.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to screen QT-prolonging drugs routinely; leaves open optimal risk-stratification tools for polypharmacy.
In this review drug-induced long QT interval syndrome is described. The authors discuss approaches for the prevention, diagnosis, and treatment of this potentially fatal complication.
No takes yet. Share an insight, caveat, or question.
Golovina et al. (2020) conducted a review in Drug-induced long QT syndrome. QT-prolonging drugs was evaluated. Drug-induced long QT syndrome is a potentially fatal complication of various cardiac and non-cardiac medications requiring prompt diagnosis, risk factor correction, and offending drug withdrawal.
Synapse has enriched 10 related papers. Consider them for comparative context: